“It’s pretty clear to us… that cannabinoids have anti-tumor properties.”
Renowned medical cannabis researcher and molecular biologist Cristina Sanchez, PhD explains “The Anti-Tumor Effects of Cannabinoid–Based Therapies on Breast Cancer Subtypes,” focusing on new cannabinoid receptors and their involvement in cannabinoid anti-tumoral action in breast cancer and other types of tumors.
In this presentation, Dr. Sanchez describes how, in pre-clinical models of cancer:
• Cannabinoids like THC and CBD exhibit cancer-fighting traits when targeted toward specific receptors and breast cancer tumors.
• How all breast cancer subtypes (Hormone Sensitive, HER 2+, Triple Negative) respond to cannabinoids.
• How whole-plant cannabinoid extracts (per entourage effects) were more potent than pure cannabinoid isolates.
To discover more about cancer and cannabis or see the entire CannMed cannabis medical conference go to: